JPWO2023015309A5 - - Google Patents
Info
- Publication number
- JPWO2023015309A5 JPWO2023015309A5 JP2024507108A JP2024507108A JPWO2023015309A5 JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5 JP 2024507108 A JP2024507108 A JP 2024507108A JP 2024507108 A JP2024507108 A JP 2024507108A JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- prime editor
- acid sequence
- prime
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163230688P | 2021-08-06 | 2021-08-06 | |
| US63/230,688 | 2021-08-06 | ||
| US202263388888P | 2022-07-13 | 2022-07-13 | |
| US63/388,888 | 2022-07-13 | ||
| PCT/US2022/074628 WO2023015309A2 (en) | 2021-08-06 | 2022-08-05 | Improved prime editors and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024530487A JP2024530487A (ja) | 2024-08-21 |
| JP2024530487A5 JP2024530487A5 (https=) | 2025-08-20 |
| JPWO2023015309A5 true JPWO2023015309A5 (https=) | 2025-08-20 |
Family
ID=83188605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024507108A Pending JP2024530487A (ja) | 2021-08-06 | 2022-08-05 | 改善されたプライムエディターおよび使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250270593A1 (https=) |
| EP (1) | EP4381057A2 (https=) |
| JP (1) | JP2024530487A (https=) |
| AU (1) | AU2022325166A1 (https=) |
| CA (1) | CA3227004A1 (https=) |
| WO (1) | WO2023015309A2 (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9388430B2 (en) | 2013-09-06 | 2016-07-12 | President And Fellows Of Harvard College | Cas9-recombinase fusion proteins and uses thereof |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| WO2016022363A2 (en) | 2014-07-30 | 2016-02-11 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| EP3592853A1 (en) | 2017-03-09 | 2020-01-15 | President and Fellows of Harvard College | Suppression of pain by gene editing |
| JP2020510038A (ja) | 2017-03-09 | 2020-04-02 | プレジデント アンド フェローズ オブ ハーバード カレッジ | がんワクチン |
| WO2019023680A1 (en) | 2017-07-28 | 2019-01-31 | President And Fellows Of Harvard College | METHODS AND COMPOSITIONS FOR EVOLUTION OF BASIC EDITORS USING PHAGE-ASSISTED CONTINUOUS EVOLUTION (PACE) |
| WO2019118949A1 (en) | 2017-12-15 | 2019-06-20 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US12522807B2 (en) | 2018-07-09 | 2026-01-13 | The Broad Institute, Inc. | RNA programmable epigenetic RNA modifiers and uses thereof |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| JP7657726B2 (ja) | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| US12473543B2 (en) | 2019-04-17 | 2025-11-18 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| JP2024533311A (ja) | 2021-09-08 | 2024-09-12 | フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー | ゲノムを調節するための方法及び組成物 |
| KR20240099164A (ko) | 2021-09-08 | 2024-06-28 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | Pah-조절 조성물 및 방법 |
| WO2024077267A1 (en) | 2022-10-07 | 2024-04-11 | The Broad Institute, Inc. | Prime editing methods and compositions for treating triplet repeat disorders |
| CN118995664B (zh) * | 2023-05-22 | 2026-03-20 | 江西农业大学 | 基于perv逆转录酶的先导编辑系统 |
| WO2024243415A1 (en) | 2023-05-23 | 2024-11-28 | The Broad Institute, Inc. | Evolved and engineered prime editors with improved editing efficiency |
| AU2024301706A1 (en) | 2023-07-21 | 2026-02-05 | Crispr Therapeutics Ag | Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene |
| WO2025048436A1 (ko) * | 2023-08-29 | 2025-03-06 | 성균관대학교산학협력단 | Eys 유전자 교정 프라임 에디터 및 그 용도 |
| WO2025096936A2 (en) | 2023-11-03 | 2025-05-08 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cdkl5 |
| WO2025151814A1 (en) | 2024-01-10 | 2025-07-17 | The Broad Institute, Inc. | Use of prime editing in correcting mutations in cftr |
| WO2025217616A1 (en) | 2024-04-12 | 2025-10-16 | The Broad Institute, Inc. | Prime editing and base editing of the atp1a3 gene for the treatment of alternating hemiplegia of childhood |
| WO2026015829A2 (en) * | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Small reverse transcriptases and gene editing systems comprising such |
| WO2026015832A2 (en) * | 2024-07-12 | 2026-01-15 | Arbor Biotechnologies, Inc. | Reverse transcriptases and gene editing systems comprising such |
| WO2026069163A1 (en) | 2024-09-25 | 2026-04-02 | Crispr Therapeutics Ag | Differentiation method for producing immature beta cells |
| CN120536504B (zh) * | 2025-07-29 | 2026-01-06 | 江西农业大学 | 基于内源性多基因编辑的阿尔茨海默病模型猪的构建方法 |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4186183A (en) | 1978-03-29 | 1980-01-29 | The United States Of America As Represented By The Secretary Of The Army | Liposome carriers in chemotherapy of leishmaniasis |
| US4261975A (en) | 1979-09-19 | 1981-04-14 | Merck & Co., Inc. | Viral liposome particle |
| US4485054A (en) | 1982-10-04 | 1984-11-27 | Lipoderm Pharmaceuticals Limited | Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV) |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5049386A (en) | 1985-01-07 | 1991-09-17 | Syntex (U.S.A.) Inc. | N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4946787A (en) | 1985-01-07 | 1990-08-07 | Syntex (U.S.A.) Inc. | N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US4774085A (en) | 1985-07-09 | 1988-09-27 | 501 Board of Regents, Univ. of Texas | Pharmaceutical administration systems containing a mixture of immunomodulators |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5244797B1 (en) | 1988-01-13 | 1998-08-25 | Life Technologies Inc | Cloned genes encoding reverse transcriptase lacking rnase h activity |
| US5264618A (en) | 1990-04-19 | 1993-11-23 | Vical, Inc. | Cationic lipids for intracellular delivery of biologically active molecules |
| WO1991017424A1 (en) | 1990-05-03 | 1991-11-14 | Vical, Inc. | Intracellular delivery of biologically active substances by means of self-assembling lipid complexes |
| US6534261B1 (en) | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| CA2392490A1 (en) | 1999-11-24 | 2001-05-31 | Mcs Micro Carrier Systems Gmbh | Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells |
| US8178291B2 (en) | 2005-02-18 | 2012-05-15 | Monogram Biosciences, Inc. | Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors |
| US9783791B2 (en) | 2005-08-10 | 2017-10-10 | Agilent Technologies, Inc. | Mutant reverse transcriptase and methods of use |
| EP2137300B1 (en) | 2007-04-26 | 2011-10-26 | Ramot at Tel-Aviv University Ltd. | Pluripotent autologous stem cells from oral or gastrointestinal mucosa |
| EP2342336B1 (en) | 2008-09-05 | 2016-12-14 | President and Fellows of Harvard College | Continuous directed evolution of proteins and nucleic acids |
| BRPI1009221A2 (pt) | 2009-03-04 | 2016-03-15 | Univ Texas | proteínas de fusão transcriptase reversa estabilizadas. |
| US8889394B2 (en) | 2009-09-07 | 2014-11-18 | Empire Technology Development Llc | Multiple domain proteins |
| US9458484B2 (en) | 2010-10-22 | 2016-10-04 | Bio-Rad Laboratories, Inc. | Reverse transcriptase mixtures with improved storage stability |
| EP3202903B1 (en) | 2010-12-22 | 2020-02-12 | President and Fellows of Harvard College | Continuous directed evolution |
| EP2761006B1 (en) | 2011-09-28 | 2016-12-14 | Zera Intein Protein Solutions, S.L. | Split inteins and uses thereof |
| DK3431497T3 (da) | 2012-06-27 | 2022-10-10 | Univ Princeton | Spaltede inteiner, konjugater og anvendelser deraf |
| WO2014055778A2 (en) | 2012-10-03 | 2014-04-10 | Agrivida, Inc. | Multiprotein expression cassettes |
| JO3470B1 (ar) | 2012-10-08 | 2020-07-05 | Merck Sharp & Dohme | مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US10179911B2 (en) | 2014-01-20 | 2019-01-15 | President And Fellows Of Harvard College | Negative selection and stringency modulation in continuous evolution systems |
| WO2016069774A1 (en) | 2014-10-28 | 2016-05-06 | Agrivida, Inc. | Methods and compositions for stabilizing trans-splicing intein modified proteases |
| WO2016168631A1 (en) | 2015-04-17 | 2016-10-20 | President And Fellows Of Harvard College | Vector-based mutagenesis system |
| US9580698B1 (en) | 2016-09-23 | 2017-02-28 | New England Biolabs, Inc. | Mutant reverse transcriptase |
| WO2018226855A1 (en) * | 2017-06-06 | 2018-12-13 | The General Hospital Corporation | Engineered crispr-cas9 nucleases |
| EP3707252A1 (en) * | 2017-11-10 | 2020-09-16 | Novozymes A/S | Temperature-sensitive cas9 protein |
| JP7657726B2 (ja) * | 2019-03-19 | 2025-04-07 | ザ ブロード インスティテュート，インコーポレーテッド | 編集ヌクレオチド配列を編集するための方法および組成物 |
| US20220411768A1 (en) * | 2019-10-21 | 2022-12-29 | The Trustees Of Columbia University In The City Of New York | Methods of performing rna templated genome editing |
| IL296024A (en) * | 2020-03-04 | 2022-10-01 | Flagship Pioneering Innovations Vi Llc | Methods and compositions for modulating a genome |
-
2022
- 2022-08-05 WO PCT/US2022/074628 patent/WO2023015309A2/en not_active Ceased
- 2022-08-05 JP JP2024507108A patent/JP2024530487A/ja active Pending
- 2022-08-05 CA CA3227004A patent/CA3227004A1/en active Pending
- 2022-08-05 AU AU2022325166A patent/AU2022325166A1/en active Pending
- 2022-08-05 US US18/681,490 patent/US20250270593A1/en active Pending
- 2022-08-05 EP EP22764605.6A patent/EP4381057A2/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2023015309A5 (https=) | ||
| Edwards et al. | Automated DNA sequencing of the human HPRT locus | |
| JP2024038327A5 (https=) | ||
| CN109072235B (zh) | 通过核递送crispr/cas9追踪并操纵细胞rna | |
| JP2022062143A (ja) | 腎臓病の処置のための組成物と方法 | |
| JPS62501470A (ja) | 腫瘍壊死因子の精製、製造および使用法 | |
| AU7406700A (en) | Design of high affinity rnase h recruiting oligonucleotide | |
| JP2002519038A (ja) | 多様性の高いライブラリーを製造する方法 | |
| JPS60252496A (ja) | 新規なヒト生理活性ポリペプチド | |
| CN108350454A (zh) | 等位基因选择性基因编辑及其用途 | |
| JP2017510542A5 (https=) | ||
| Tinker et al. | Transcriptional activation by a DNA-tracking protein: structural consequences of enhancement at the T4 late promoter | |
| US5405775A (en) | Retrons coding for hybrid DNA/RNA molecules | |
| JP7684298B2 (ja) | Ｒｎａ分子を合成する方法 | |
| CN117337329A (zh) | 环状rna | |
| WO2023096977A2 (en) | Modified prime editing guide rnas | |
| EP4430185A1 (en) | Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy | |
| JP2008519602A (ja) | 多様性を生じるためのラダーアセンブリおよびシステム | |
| JP2021522825A5 (https=) | ||
| JPWO2022256440A5 (https=) | ||
| JPS6070086A (ja) | コロナウイルス用ワクチンの調製方法 | |
| JPWO2023039586A5 (https=) | ||
| IL304969A (en) | Curing disease by transcription regulatory gene editing | |
| JPWO2023004409A5 (https=) | ||
| JP3680392B2 (ja) | マイクロ遺伝子のランダム重合体作成方法 |